Global stock

NYSEUSD

Veeva Systems Inc.

VEEV

AI analysis and articles are in Czech.

§ Financial healthLong-term stability

59/ 100

Overall score·VEEV

Current price

318.18USD

26/10/2026

P/E, P/B

Valuation

Weak

Rates whether the stock is cheap or expensive relative to its history and sector. A score above 60 suggests the stock trades below its estimated intrinsic value.

Tracks:P/E · P/B · FCF yield · sector

Veeva se obchoduje nad sektorovým průměrem P/E, což naznačuje nadhodnocení. Růst tržeb je silný, avšak zadluženost je nadprůměrná. Trend ukazuje na růst, ale nálada trhu je mírně opatrný.

§ Outlook vs S&P 500Next 12 months

Probably yes

Estimated chance of beating the index: about 55%

8 of 8 inputs

NoProbably notSameProbably yesYes

A model estimate from current values. The result may change with new data; it is not a price target or an investment recommendation.

§ Context and events

Management

Zakladatel Peter P. Gassner je CEO a člen představenstva; Eleni Nitsa Zuppas působí jako prezidentka a Chief of Staff a Brian Van Wagener jako CFO. Strategie Veevy stojí na rozšiřování cloudové platformy Vault pro farmaceutické firmy a na získávání zákazníků pro vlastní CRM řešení.

Articles about Veeva Systems Inc., in Czech (0)

No articles yet. New analyses are published daily.

§ Upcoming results

25 November 2026

in 29 days

Earnings

Earnings = quarterly financial results (revenue and profit). Companies publish them every three months and the share price often reacts strongly.

§ Frequently asked questions

What is Veeva Systems Inc. (VEEV)?

Veeva Systems Inc. (VEEV) is a global stock traded on NYSE. Sector: Healthcare. We track it daily — scoring news sentiment, the short-term outlook and long-term stability on a 0–100 scale.

What is the Veeva Systems Inc. price today?

As of 26 October 2026, Veeva Systems Inc. trades at about 318.18 USD per unit. We update the price daily from public market data. Intraday moves can differ significantly — always check the final price with your broker.

How to buy Veeva Systems Inc.?

Through regulated online brokers such as Degiro, XTB, Trading 212 or Interactive Brokers. Shares trade in USD or EUR — most brokers convert your currency automatically. FinSignal does not operate any of these platforms and charges no commission — the overview is only a signpost.

Does Veeva Systems Inc. pay a dividend?

Veeva Systems Inc. either pays no dividend at the moment or we have no reliable data on it. Many growth companies prefer reinvesting profit to paying dividends — check the current policy in the company's investor relations materials.

Is Veeva Systems Inc. a good investment in 2026?

Our AI signal currently rates Veeva Systems Inc. as slightly positive (score 63/100). Financial health comes out at 59/100, so beyond short-term news it is worth watching the valuation, growth, profitability and stability of the company. FinSignal is not an investment adviser licensed under Czech Act No. 256/2004 Coll. — signals are analytical input, not a recommendation to buy or sell. You make every decision at your own risk.

§ More global stocks

Microsoft Corporation

MSFThealth 73/100

§ How to buy Veeva Systems Inc.

You can buy shares through regulated online brokers available in the EU. They differ mainly in fees, app quality and which markets they cover.

Degiro
Dutch broker with low fees for passive investors. No account fee, trading in EUR and USD.
XTB
Polish broker with zero commission on stocks and ETFs up to EUR 100,000 a month. Own xStation platform.
Trading 212
Zero-commission broker with fractional shares from EUR 1 and automated investing (Pies). Suits beginners and regular investing.
Interactive Brokers
US broker for advanced investors. The widest choice of markets, low costs at larger volumes, a professional platform with a steeper learning curve.

FinSignal operates none of these platforms. We charge no commission on purchases.

Important: Signals are an analytical tool, not investment advice within the meaning of Czech Act No. 256/2004 Coll. Past performance does not guarantee future results. You make all decisions at your own risk.

§ Current signalShort-term mood

/ 100

● Slightly positive

News summary

Fresh news

Signal 27/10, 04:02

Akcie Veevy klesly, přestože širší trh rostl; pokles by mohl tlumit výhled, pokud se potvrdí jako trvalejší, zatímco růstový trend jej zatím vyvažuje.

Růst ceny za 30 dní a rostoucí trend podporují výhled, ale týdenní změna je malá a RSI 72 značí překoupenost. Kvalitní obchodní model podporuje stabilitu, ocenění a vysoká volatilita ji omezují.

Risks: Pokračující pokles navzdory růstu trhu nebo zpomalení firemního růstu by zpochybnily býčí výhled.

More about the signal

Risks: Pokračující pokles navzdory růstu trhu nebo zpomalení firemního růstu by zpochybnily býčí výhled.

Signal history· 2

24/1015:0273 · Strongly positive
Baird zvýšil cílovou cenu Veevy z 300 na 350 USD; srpnový výhled firmy počítá s vyšším ziskem i tržbami. Dopad podpoří plnění výhledu, omezit jej může zpomalení růstu.
23/1010:0259 · Slightly positive
Zpráva z 21. října 2026 se ptá, zda jsou akcie Veevy drahé; její dopad závisí na tom, zda ocenění podpoří další růst firmy.

The full 90-day signal history is part of Premium.

Ask the AI

DCF valuation

A DCF model is not suitable for this asset class.

§ Valuation check

Is the price reasonable?

Six quick tests: price against fair value, the last year, similar companies and analyst estimates. They are calculated from the numbers, not from AI estimates. This is not a recommendation.

Data 18 of 18

Valuation score

1/ 6

4/6 tests available

1. Below DCF fair value

The complete DCF range or the current price is missing.

2. Well below DCF value

The complete DCF range or the current price is missing.

3. Price vs. the last year

97% above the 1-year low (151.4 USD to 323.0 USD), based on stored daily prices.

4. P/E vs. similar companies

P/E 44.8 vs. median 26.4 (71 companies).

5. P/E relative to growth

PEG 1.1; a lower value means cheaper growth.

6. Analyst price target

-6.6% vs. the current price, 27 analysts.

Price and fair value

no complete range

The DCF check appears once both the price and the model range are available.

Price vs analyst target

Current price

318.2 USD

Low 180.0 USDHigh 350.0 USD

Current priceAverage: 297.3 USD

DCF gap

no complete range

The DCF check appears once both the price and the model range are available.

Analyst target

-6.6%

Average target 297.3 USD vs. price 318.2 USD.

Analyst consensus

Target range

180.0 USD - 350.0 USD

Coverage

27 analysts

Analyst consensus

2.0 / 5

Changes 180 d

+0 / -1

EPS next year

11.0%

Revenue next year

12.3%

Valuation multiples

44.8

26.7

6.1

12.8

34.6

1.1

52-week range97% above the low

151.4 USD323.0 USD

40.0%

18.0%

29.3%

14.4%

Price vs 50D26.9%

Price vs 200D58.1%

Metrics explained+

Price and fair value

DCF range: A model estimate of fair value from future free cash flow. A price above the range means the market pays a premium over the model; a price below it may signal a more conservative market valuation or an overly optimistic model.
Analyst target: The average and range of the analyst price targets we track. It is the market consensus, not a FinSignal recommendation, and it can lag fast price moves.
52-week range: Shows where the current price sits between the low and high of the last year. A value near the high often signals strong momentum, but on its own says nothing about whether the stock is expensive.
Price vs 50D / 200D: Compares the price with its short- and long-term moving averages. A positive value means the price is above the trend; a negative one below it.

Multiples

P/E: Price relative to current earnings. A lower P/E can mean cheaper, but it can also point to a weak outlook or risk.
Forward P/E: Price relative to next year's expected earnings. For growing companies it is often more useful than the historical P/E because it reflects estimates of future earnings.
P/B: Price relative to the book value of equity. It makes more sense for banks, insurers and capital-intensive companies than for software or brands.
P/S: Price relative to revenue. It helps with companies that have low or negative earnings; a high P/S means the market expects strong growth or future margins.
EV/EBITDA: The value of the whole company, including debt, relative to operating profit before depreciation. Useful for comparing companies with different leverage.
PEG: P/E adjusted for earnings growth. A value around 1 may suggest the valuation matches growth, but the metric is sensitive to estimates.

Growth and quality

EPS growth: Year-on-year change in earnings per share. Strong growth supports a higher valuation, but for cyclical companies it can be temporary.
Revenue growth: The growth rate of sales. It helps tell whether profits grow on real demand or mainly on cost savings.
Net margin: How much of each unit of revenue is left as net profit. A higher margin often points to stronger pricing power or more efficient operations.
ROE: Return on equity. A high ROE can signal a quality business, but check that it is not artificially boosted by heavy debt.

Most data available. Missing values mean the market data source did not provide them for this ticker. The data is indicative and may be delayed. Price as of 26/10/2026.

Management and competitive advantage

Both are estimated by the AI from the company profile, news and results. They do not count towards the 6-pillar financial health score. The AI comments are in Czech.

good

Management má průměrné hodnocení, přičemž silné stránky jsou v růstu a strategických rozšířeních, ale governance rizika snižují celkovou důvěru.

good

Veeva má udržitelnou konkurenční výhodu díky silnému portfoliu cloudových řešení a značce, i když vysoká konkurence a závislost na klíčových zákaznících představují slabší stránky.

Information

Type: Global stock
Symbol: VEEV
Exchange: NYSE
Currency: USD
Sector: Healthcare
: 44.8x
: 44.3B USD
: 2.0 %
: 0.97

§ Risk profile

Rizikem je konkurence v podnikovém softwaru, závislost na farmaceutických zákaznících a vysoká očekávání investorů ohledně růstu. České korunové výnosy navíc ovlivňuje kurz USD/CZK.

Ask the AI about Veeva Systems Inc.All signals